Cargando…
A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review
Background and Motivation: Cardiovascular disease (CVD) causes the highest mortality globally. With escalating healthcare costs, early non-invasive CVD risk assessment is vital. Conventional methods have shown poor performance compared to more recent and fast-evolving Artificial Intelligence (AI) me...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947682/ https://www.ncbi.nlm.nih.gov/pubmed/35328275 http://dx.doi.org/10.3390/diagnostics12030722 |
_version_ | 1784674497683521536 |
---|---|
author | Suri, Jasjit S. Bhagawati, Mrinalini Paul, Sudip Protogerou, Athanasios D. Sfikakis, Petros P. Kitas, George D. Khanna, Narendra N. Ruzsa, Zoltan Sharma, Aditya M. Saxena, Sanjay Faa, Gavino Laird, John R. Johri, Amer M. Kalra, Manudeep K. Paraskevas, Kosmas I. Saba, Luca |
author_facet | Suri, Jasjit S. Bhagawati, Mrinalini Paul, Sudip Protogerou, Athanasios D. Sfikakis, Petros P. Kitas, George D. Khanna, Narendra N. Ruzsa, Zoltan Sharma, Aditya M. Saxena, Sanjay Faa, Gavino Laird, John R. Johri, Amer M. Kalra, Manudeep K. Paraskevas, Kosmas I. Saba, Luca |
author_sort | Suri, Jasjit S. |
collection | PubMed |
description | Background and Motivation: Cardiovascular disease (CVD) causes the highest mortality globally. With escalating healthcare costs, early non-invasive CVD risk assessment is vital. Conventional methods have shown poor performance compared to more recent and fast-evolving Artificial Intelligence (AI) methods. The proposed study reviews the three most recent paradigms for CVD risk assessment, namely multiclass, multi-label, and ensemble-based methods in (i) office-based and (ii) stress-test laboratories. Methods: A total of 265 CVD-based studies were selected using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) model. Due to its popularity and recent development, the study analyzed the above three paradigms using machine learning (ML) frameworks. We review comprehensively these three methods using attributes, such as architecture, applications, pro-and-cons, scientific validation, clinical evaluation, and AI risk-of-bias (RoB) in the CVD framework. These ML techniques were then extended under mobile and cloud-based infrastructure. Findings: Most popular biomarkers used were office-based, laboratory-based, image-based phenotypes, and medication usage. Surrogate carotid scanning for coronary artery risk prediction had shown promising results. Ground truth (GT) selection for AI-based training along with scientific and clinical validation is very important for CVD stratification to avoid RoB. It was observed that the most popular classification paradigm is multiclass followed by the ensemble, and multi-label. The use of deep learning techniques in CVD risk stratification is in a very early stage of development. Mobile and cloud-based AI technologies are more likely to be the future. Conclusions: AI-based methods for CVD risk assessment are most promising and successful. Choice of GT is most vital in AI-based models to prevent the RoB. The amalgamation of image-based strategies with conventional risk factors provides the highest stability when using the three CVD paradigms in non-cloud and cloud-based frameworks. |
format | Online Article Text |
id | pubmed-8947682 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89476822022-03-25 A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review Suri, Jasjit S. Bhagawati, Mrinalini Paul, Sudip Protogerou, Athanasios D. Sfikakis, Petros P. Kitas, George D. Khanna, Narendra N. Ruzsa, Zoltan Sharma, Aditya M. Saxena, Sanjay Faa, Gavino Laird, John R. Johri, Amer M. Kalra, Manudeep K. Paraskevas, Kosmas I. Saba, Luca Diagnostics (Basel) Review Background and Motivation: Cardiovascular disease (CVD) causes the highest mortality globally. With escalating healthcare costs, early non-invasive CVD risk assessment is vital. Conventional methods have shown poor performance compared to more recent and fast-evolving Artificial Intelligence (AI) methods. The proposed study reviews the three most recent paradigms for CVD risk assessment, namely multiclass, multi-label, and ensemble-based methods in (i) office-based and (ii) stress-test laboratories. Methods: A total of 265 CVD-based studies were selected using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) model. Due to its popularity and recent development, the study analyzed the above three paradigms using machine learning (ML) frameworks. We review comprehensively these three methods using attributes, such as architecture, applications, pro-and-cons, scientific validation, clinical evaluation, and AI risk-of-bias (RoB) in the CVD framework. These ML techniques were then extended under mobile and cloud-based infrastructure. Findings: Most popular biomarkers used were office-based, laboratory-based, image-based phenotypes, and medication usage. Surrogate carotid scanning for coronary artery risk prediction had shown promising results. Ground truth (GT) selection for AI-based training along with scientific and clinical validation is very important for CVD stratification to avoid RoB. It was observed that the most popular classification paradigm is multiclass followed by the ensemble, and multi-label. The use of deep learning techniques in CVD risk stratification is in a very early stage of development. Mobile and cloud-based AI technologies are more likely to be the future. Conclusions: AI-based methods for CVD risk assessment are most promising and successful. Choice of GT is most vital in AI-based models to prevent the RoB. The amalgamation of image-based strategies with conventional risk factors provides the highest stability when using the three CVD paradigms in non-cloud and cloud-based frameworks. MDPI 2022-03-16 /pmc/articles/PMC8947682/ /pubmed/35328275 http://dx.doi.org/10.3390/diagnostics12030722 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Suri, Jasjit S. Bhagawati, Mrinalini Paul, Sudip Protogerou, Athanasios D. Sfikakis, Petros P. Kitas, George D. Khanna, Narendra N. Ruzsa, Zoltan Sharma, Aditya M. Saxena, Sanjay Faa, Gavino Laird, John R. Johri, Amer M. Kalra, Manudeep K. Paraskevas, Kosmas I. Saba, Luca A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review |
title | A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review |
title_full | A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review |
title_fullStr | A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review |
title_full_unstemmed | A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review |
title_short | A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review |
title_sort | powerful paradigm for cardiovascular risk stratification using multiclass, multi-label, and ensemble-based machine learning paradigms: a narrative review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947682/ https://www.ncbi.nlm.nih.gov/pubmed/35328275 http://dx.doi.org/10.3390/diagnostics12030722 |
work_keys_str_mv | AT surijasjits apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT bhagawatimrinalini apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT paulsudip apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT protogerouathanasiosd apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT sfikakispetrosp apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT kitasgeorged apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT khannanarendran apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT ruzsazoltan apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT sharmaadityam apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT saxenasanjay apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT faagavino apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT lairdjohnr apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT johriamerm apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT kalramanudeepk apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT paraskevaskosmasi apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT sabaluca apowerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT surijasjits powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT bhagawatimrinalini powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT paulsudip powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT protogerouathanasiosd powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT sfikakispetrosp powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT kitasgeorged powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT khannanarendran powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT ruzsazoltan powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT sharmaadityam powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT saxenasanjay powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT faagavino powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT lairdjohnr powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT johriamerm powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT kalramanudeepk powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT paraskevaskosmasi powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview AT sabaluca powerfulparadigmforcardiovascularriskstratificationusingmulticlassmultilabelandensemblebasedmachinelearningparadigmsanarrativereview |